Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Formation Of Antibodies And Subsequent Prediction Of Clinical Response In Patients With Rheumatoid Arthritis Treated With Four Tnf Blocking Agents

NCT01691014 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01691014
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01691014 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Formation Of Antibodies And Subsequent Prediction Of Clinical Response In Patients With Rheumatoid Arthritis Treated With Four Tnf Blocking Agents
Lead sponsor
Pfizer
Phase
Observational
Overall status
Terminated
Start date
April 30, 2013
Completion date
January 31, 2015
Enrollment
79 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis (ra)